Pieter Van der Veken

6.9k total citations
184 papers, 5.4k citations indexed

About

Pieter Van der Veken is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pieter Van der Veken has authored 184 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 69 papers in Molecular Biology and 51 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pieter Van der Veken's work include Peptidase Inhibition and Analysis (76 papers), Neuropeptides and Animal Physiology (49 papers) and Diabetes Treatment and Management (22 papers). Pieter Van der Veken is often cited by papers focused on Peptidase Inhibition and Analysis (76 papers), Neuropeptides and Animal Physiology (49 papers) and Diabetes Treatment and Management (22 papers). Pieter Van der Veken collaborates with scholars based in Belgium, Germany and United States. Pieter Van der Veken's co-authors include Koen Augustyns, Anne‐Marie Lambeir, Ingrid De Meester, Achiel Haemers, Jurgen Joossens, Kristel Senten, Simon Scharpé, Louis Maes, Paul Cos and Jonathan D. Cheng and has published in prestigious journals such as Environmental Science & Technology, PLoS ONE and Cancer Research.

In The Last Decade

Pieter Van der Veken

180 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pieter Van der Veken Belgium	41	1.9k	1.8k	1.0k	968	720	184	5.4k
Michael J. Evans United States	48	973 0.5×	2.6k 1.5×	573 0.6×	395 0.4×	825 1.1×	186	9.2k
Jing‐Jer Lin Taiwan	45	695 0.4×	5.1k 2.9×	373 0.4×	186 0.2×	621 0.9×	176	6.8k
Fuquan Yang China	43	1.0k 0.5×	4.7k 2.6×	99 0.1×	107 0.1×	1.4k 2.0×	173	7.9k
Liang Qiao China	40	1.2k 0.6×	2.7k 1.5×	230 0.2×	84 0.1×	1.5k 2.1×	142	5.6k
Liping Liu China	32	421 0.2×	2.5k 1.4×	163 0.2×	128 0.1×	973 1.4×	99	4.7k
Lee M. Graves United States	52	1.2k 0.6×	5.3k 2.9×	227 0.2×	395 0.4×	926 1.3×	173	8.0k
Shuang Liu China	41	882 0.5×	3.2k 1.8×	341 0.3×	139 0.1×	831 1.2×	242	6.5k
Joseph P. Brown United States	44	827 0.4×	2.7k 1.5×	381 0.4×	52 0.1×	669 0.9×	116	6.4k
Xiaoqing Li China	42	1.3k 0.7×	3.1k 1.7×	61 0.1×	193 0.2×	1.2k 1.6×	271	5.9k
Hideo Takahashi Japan	36	507 0.3×	2.1k 1.2×	256 0.2×	105 0.1×	268 0.4×	204	4.4k

Countries citing papers authored by Pieter Van der Veken

Since Specialization

Citations

This map shows the geographic impact of Pieter Van der Veken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Van der Veken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Van der Veken more than expected).

Fields of papers citing papers by Pieter Van der Veken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter Van der Veken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Van der Veken. The network helps show where Pieter Van der Veken may publish in the future.

Co-authorship network of co-authors of Pieter Van der Veken

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Van der Veken. A scholar is included among the top collaborators of Pieter Van der Veken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Van der Veken. Pieter Van der Veken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klejborowska, Greta, Ashley M. Toye, Emily Van San, et al.. (2025). Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases. Journal of Medicinal Chemistry. 68(4). 4908–4928. 2 indexed citations

Foubert, Kenn, Mart Theunis, Tania Naessens, et al.. (2024). UPLC-TQD-MS/MS Method Validation for Quality Control of Alkaloid Content in Lepidium meyenii (Maca)-Containing Food and Dietary Supplements. ACS Omega. 9(14). 15971–15981. 1 indexed citations

Poulie, Christian B. M., Vladimir Shalgunov, Filipe Elvas, et al.. (2023). Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to 18F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines. European Journal of Medicinal Chemistry. 262. 115862–115862. 10 indexed citations

Maes, Bert U. W., et al.. (2021). Strecker-Derived Methodology for Library Synthesis of N-Acylated α-Aminonitriles. ACS Omega. 6(2). 1328–1338. 5 indexed citations

Salado, Irene G., Abhimanyu K. Singh, Marco Siderius, et al.. (2020). Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds. Journal of Medicinal Chemistry. 63(7). 3485–3507. 6 indexed citations

Gärtner, Florian, Milka Marinova, Ulrike Attenberger, et al.. (2020). [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging. Nuklearmedizin - NuclearMedicine. 59(5). 387–389. 16 indexed citations

Rompaey, Dries Van, et al.. (2019). Efforts towards an On‐Target Version of the Groebke–Blackburn–Bienaymé (GBB) Reaction for Discovery of Druglike Urokinase (uPA) Inhibitors. Chemistry - A European Journal. 25(53). 12380–12393. 12 indexed citations

Ceuleers, Hannah, Nikita Hanning, Jurgen Joossens, et al.. (2018). Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome. British Journal of Pharmacology. 175(17). 3516–3533. 36 indexed citations

Tsirigotaki, Alexandra, Roos Van Elzen, Pieter Van der Veken, Anne‐Marie Lambeir, & Anastassios Economou. (2017). Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry. Scientific Reports. 7(1). 2456–2456. 20 indexed citations

10.

Wyffels, Leonie, David Thomae, Ann‐Marie Waldron, et al.. (2014). In vivo evaluation of 18F-labeled TCO for pre-targeted PET imaging in the brain. Nuclear Medicine and Biology. 41(6). 513–523. 31 indexed citations

11.

Ariën, Kevin K., Jan Heeres, Jurgen Joossens, et al.. (2014). From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds. Bioorganic & Medicinal Chemistry. 22(19). 5241–5248. 11 indexed citations

12.

Jansen, Koen, Jonathan D. Cheng, Jurgen Joossens, et al.. (2013). Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold. ACS Medicinal Chemistry Letters. 4(5). 491–496. 194 indexed citations

13.

Tenorio‐Laranga, Jofre, Pekka T. Männistö, Markus Storvik, Pieter Van der Veken, & J. Arturo García‐Horsman. (2012). Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney. Biochimie. 94(9). 1849–1859. 18 indexed citations

14.

Matheeussen, Veerle, Lesley Baerts, Guido R.Y. De Meyer, et al.. (2011). Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biological Chemistry. 392(3). 189–98. 59 indexed citations

15.

Govaerts, Bernadette, et al.. (2010). Occupational exposure to noise and the prevalence of hearing loss in a Belgian military population: A cross-sectional study. Noise and Health. 13(50). 64–64. 39 indexed citations

16.

Sayed, Ibrahim El Tantawy El, Pieter Van der Veken, Liene Dhooghe, et al.. (2009). Synthesis and Antiplasmodial Activity of Aminoalkylamino-Substituted Neocryptolepine Derivatives. Journal of Medicinal Chemistry. 52(9). 2979–2988. 74 indexed citations

17.

Veken, Pieter Van der, Véronique Dubois, Anne‐Marie Lambeir, et al.. (2008). Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: Isoindoline containing inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4159–4162. 62 indexed citations

18.

Sayed, Ibrahim El Tantawy El, Pieter Van der Veken, Alisa Krishtal, et al.. (2007). Dipeptidyl α-fluorovinyl Michael acceptors: Synthesis and activity against cysteine proteases. Bioorganic & Medicinal Chemistry Letters. 17(23). 6563–6566. 29 indexed citations

19.

Maes, Marie-Berthe, Wim Martinet, D. Schrijvers, et al.. (2006). Dipeptidyl peptidase II and leukocyte cell death. Biochemical Pharmacology. 72(1). 70–79. 15 indexed citations

20.

Augustyns, Koen, Pieter Van der Veken, Kristel Senten, & Achiel Haemers. (2003). Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes. Expert Opinion on Therapeutic Patents. 13(4). 499–510. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact